scholarly journals Quality of Life of Women with Urinary Incontinence: A Systematic Literature Review

2010 ◽  
Vol 14 (3) ◽  
pp. 133 ◽  
Author(s):  
Bo Eun Kwon ◽  
Gi Yon Kim ◽  
Youn Jung Son ◽  
Young Sook Roh ◽  
Mi Ae You
Keyword(s):  
Quality Of Life ◽  
Urinary Incontinence ◽  
Literature Review ◽  
Systematic Literature Review

scholarly journals The impact of pelvic floor muscle training on the quality of life of women with urinary incontinence: a systematic literature review

2018 ◽  
Vol Volume 13 ◽  
pp. 957-965 ◽  
Author(s):  
Agnieszka Radzimińska ◽  
Agnieszka Strączyńska ◽  
Magdalena Weber-Rajek ◽  
Hanna Styczyńska ◽  
Katarzyna Strojek ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Urinary Incontinence ◽  
Literature Review ◽  
Pelvic Floor ◽  
Systematic Literature Review ◽  
Pelvic Floor Muscle Training ◽  
Pelvic Floor Muscle ◽  
Muscle Training ◽  
The Impact

scholarly journals 593 Quality of life following a road traffic injury: a systematic literature review

2016 ◽  
Vol 22 (Suppl 2) ◽  
pp. A213.1-A213
Author(s):  
Ritva Rissanen ◽  
Hans-Yngve Berg ◽  
Marie Hasselberg
Keyword(s):  
Quality Of Life ◽  
Literature Review ◽  
Systematic Literature Review ◽  
Road Traffic ◽  
Road Traffic Injury ◽  
Traffic Injury

scholarly journals Quality Of Life In Patients Suffering From Psoriasis Vulgaris Using Eq5d; A Systematic Literature Review

2014 ◽  
Vol 17 (3) ◽  
pp. A288
Author(s):  
A. Moeller ◽  
S. Erntoft ◽  
G.R. Vinding ◽  
G.B.E. Jemec
Keyword(s):  
Quality Of Life ◽  
Literature Review ◽  
Systematic Literature Review ◽  
Psoriasis Vulgaris

scholarly journals A Systematic Literature Review of the Epidemiology, Health-Related Quality of Life Impact, and Economic Burden of Immunoglobulin A Nephropathy

2021 ◽  
Vol 8 (2) ◽  
pp. 36-45
Author(s):  
Christina Soeun Kwon ◽  
Patrick Daniele ◽  
Anna Forsythe ◽  
Christopher Ngai
Keyword(s):  
Quality Of Life ◽  
Literature Review ◽  
Kidney Function ◽  
Systematic Literature Review ◽  
Economic Burden ◽  
Health Related Quality ◽  
Us Studies ◽  
Related Quality ◽  
Health Related

Introduction: This systematic literature review analyzed published evidence on IgA nephropathy (IgAN), focusing on US epidemiology, health-related quality of life (HRQoL), and economic burden of illness. Methods: Using Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, Embase®, MEDLINE®, Cochrane, and Econlit (January 2010 to June 2020) were searched, along with relevant congresses (2017-2020). Results: Of 123 epidemiologic studies selected for data extraction, 24 reported IgAN diagnosis rates ranging from 6.3% to 29.7% among adult and pediatric patients undergoing renal biopsy, with all reported US rates <15%. No US studies reported IgAN prevalence. A meta-analysis of US studies calculated an annual incidence of 1.29/100 000 people, translating to an annual US incidence of 4236 adults and children. Relative to Europe, the United States had more patients diagnosed with IgAN in later chronic kidney disease stages. US rates of transition to end-stage renal disease (ESRD) ranged from 12.5% to 23% during 3-3.9 years of observation, rising to 53% during 19 years of observation. Across 8 studies reporting HRQoL, pain and fatigue were the most reported symptoms, and patients consistently ranked kidney function and mortality as the most important treatment outcomes. Patients with glomerulopathy reported worse mental health than healthy controls or hemodialysis patients; proteinuria was significantly associated with poorer HRQoL and depression. Conclusion: While economic evidence in IgAN remains sparse, management of ESRD is a major cost driver. IgAN is a rare disease where disease progression causes increasing patient burden, underscoring the need for therapies that prevent kidney function decline and HRQoL deterioration while reducing mortality.

Sign in / Sign up

Export Citation Format

Share Document